RxDoctor Payments Data

David Jaffe, MD

Foot and Ankle Surgery · Phoenix, AZNPI 1609195957

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $59,436 of the $75,339 with a category attached, or 78.9%. 30 manufacturers reported payments, led by Arthrex at 42.3% of the total. 2025 is the largest year on record at $55,447, more than ten times the $274 reported in 2019. Among foot and ankle surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$75,339in general payments, 2019–2025

Across 260 payments — averaging $289.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$32K
  • Medical Device Business Services, Inc.$22K
  • Fusion Orthopedics USA, LLC$14K
  • Impactortho, Inc.$2K
  • Johnson & Johnson$2K
  • Smith+Nephew$831
  • plus $3K from 24 others
$36,893in research payments, 2019–2025

Across 4 payments — averaging $9223.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$35K
  • Arthrex$1K

What the payments were for

  • Royalty or licence$1,2542%
  • Consulting fees$59,43679%
  • Speaking & faculty fees$4,3156%
  • Travel & lodging$2,3663%
  • Food & beverage$7,56710%
  • Education$4001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$75,339 in reported general payments places this provider in the 95th percentile of 291 foot and ankle surgery providers in Arizona.

See all foot and ankle surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$247,343
Medicare patients
470
Services billed
2,187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib67$1,167
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$326
Gabapentin66$308
Meloxicam104$237
Ondansetron Hcl43$219
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$56

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →